Clinical evaluation of a portable lactate meter in type I glycogen storage disease
- 21 January 2005
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 28 (5), 695-701
- https://doi.org/10.1007/s10545-005-0090-1
Abstract
High lactate concentrations occur in type I glycogen storage disease (GSD) whenever glycogenolysis occurs. Not only does hyperlactataemia cause acute clinical deterioration, but chronic lactate elevations have also been associated with many of the long-term complications in GSD. A portable finger-stick blood lactate meter has recently been marketed as a training tool for high-performance athletes, but it has not been tested as a clinical diagnostic tool. This study was performed to assess the accuracy of the portable lactate meter in subjects with GSD I who are predisposed to high lactate concentrations. A total of 166 intravenous and 39 capillary samples from 13 subjects were tested concomitantly on three different lactate meters. The meter readings were compared with the lactate concentration determined by the laboratory gold-standard enzymatic colorimetric assay. Almost no inter-meter variability was found. The lactate meter values had outstanding correlation with the laboratory lactate determination, although the meters were found to run 0.5 mmol/L higher than the laboratory assay. The meter deviation was independent of lactate concentration. More variability was noted with finger-stick capillary lactate determinations, but monitoring of trends with capillary samples should prove valuable as a method for determining long-term control or acute deterioration. The portable lactate meter is a highly accurate tool for monitoring lactate concentrations, and should prove valuable for monitoring metabolic control in patients with GSD type I and other disorders associated with hyperlactataemia.Keywords
This publication has 12 references indexed in Scilit:
- Glucose Sensors and the Alternate Site Testing-Like Phenomenon: Relationship Between Rapid Blood Glucose Changes and Glucose Sensor SignalsDiabetes Technology & Therapeutics, 2003
- Glycogen Storage Diseases: A Primer for CliniciansThe Endocrinologist, 2002
- Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescenceEuropean Journal of Pediatrics, 2002
- Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage diseaseEuropean Journal of Pediatrics, 2002
- Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)European Journal of Pediatrics, 2002
- Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage diseaseEuropean Journal of Pediatrics, 2002
- Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)European Journal of Pediatrics, 2002
- Urinary Lactate Excretion to Monitor the Efficacy of Treatment of Type I Glycogen Storage DiseaseMolecular Genetics and Metabolism, 2000
- Urinary lactate excretion in type 1 glycogenosis — a marker of metabolic control or renal tubular dysfunction?Journal of Inherited Metabolic Disease, 1996
- The Lactate Concentration of the Urine, a Parameter for the Adequacy of Dietary Treatment of Patients with Glucose-6-phosphatase DeficiencyJournal of Inherited Metabolic Disease, 1984